Sickle Cell Disease

• FDA approves 2 gene therapies for sickle cell disease

  The U.S. FDA on Friday approved two gene therapies for sickle cell disease from Vertex Pharmaceuticals and CRISPR Therapeutics, as well as from bluebird bio.

  Health

  Dec 8, 2023
  
• Ontario announces new clinic for EDS, expands other clinics for rare diseases

  The Ontario government says it is improving access to specialized care for people living with rare diseases.

  Health

  Feb 27, 2017
  
• Advertisement
• Renewed calls for Sask. newborns to be screened for sickle cell disease

  While rare, sickle cell disease is on the rise as the immigrant population increases, renewing calls for screening of the disease in newborns.

  Health

  Sep 30, 2015